
Monday, November 11, 2024 5:41:31 PM
The NOPAIN Act expands patient and provider access to FDA-approved non-opioids in all outpatient surgical settings beginning in 2025 by providing separate Medicare reimbursement for non-opioid therapies.
Recent ASRT News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2025 09:14:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2025 08:05:17 PM
- Assertio Reports Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 03/12/2025 08:05:00 PM
- Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 • GlobeNewswire Inc. • 03/05/2025 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:03:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:04:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:02:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:01:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 11:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:13:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:11:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:09:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2025 10:01:35 PM
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/03/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 10:00:28 PM
- Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors • GlobeNewswire Inc. • 12/17/2024 01:30:00 PM
- Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study • GlobeNewswire Inc. • 12/13/2024 01:00:00 PM
- Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO • GlobeNewswire Inc. • 12/12/2024 01:00:00 PM
- Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer • GlobeNewswire Inc. • 12/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:27:46 PM
- Assertio Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/11/2024 09:02:00 PM
- Assertio Provides Response to Letter from Short-seller • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
- Tesla Rises 5% Pre-Market After Surpassing $1T Market Value; U.S. Bans TSMC From Selling Advanced Chips to China • IH Market News • 11/11/2024 11:04:09 AM
FEATURED 4Cable TV International, Inc. Unleashes Bold Strategy to Maximize Shareholder Value with close to 7.8 billion Dilutive Shares Eliminated • Mar 18, 2025 1:15 PM
FEATURED Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection • Mar 18, 2025 8:36 AM
FEATURED Xtreme One Entertainment Announces $1.5 Million Private Placement • Mar 18, 2025 12:00 AM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM